NCT03577652View on ClinicalTrials.gov

The Optimal Strategy of Switching From Clopidogrel to Ticagrelor in Patients With Complexity of Coronary Artery Disease

NACompletedINTERVENTIONAL

Enrollment

108

Participants

Timeline

Start Date

July 10, 2017

Primary Completion Date

January 10, 2018

Study Completion Date

January 10, 2018

Conditions

Coronary Artery DiseaseTicagrelor

Interventions

DRUG

Ticagrelor

Ticagrelor, 90mg, 90mg twice daily

Trial Locations (1)

110016

General Hospital of Shenyang Military Region, Shenyang

All Listed Sponsors

lead

Shenyang Northern Hospital

OTHER

NCT03577652 - The Optimal Strategy of Switching From Clopidogrel to Ticagrelor in Patients With Complexity of Coronary Artery Disease | Biotech Hunter | Biotech Hunter